| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.096 | 0.09 |